Non-brokered offering sells 5 million common shares at C$0.60 apiece
By Devika Patel
Knoxville, Tenn., March 21 - Antibe Therapeutics Inc. said it plans a C$3 million non-brokered private placement of stock.
The company will sell 5 million common shares at C$0.60 per share, which is an 18.92% discount to the March 20 closing share price of C$0.74.
Settlement is expected March 28.
Proceeds will be used for product development and general corporate purposes.
The pharmaceutical company is based in Toronto.
| Issuer: | Antibe Therapeutics Inc.
|
| Issue: | Common stock
|
| Amount: | C$3 million
|
| Shares: | 5 million
|
| Price: | C$0.60
|
| Warrants: | No
|
| Agent: | Non-brokered
|
| Pricing date: | March 21
|
| Settlement date: | March 28
|
| Stock symbol: | TSX Venture: ATE
|
| Stock price: | C$0.74 at close March 20
|
| Market capitalization: | C$25.42 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
